Case 4-2004: A Nine-Month-Old Boy with an Orbital Rhabdomyosarcoma

New England Journal of Medicine

Volumn 350, Issue 5, 2004, Pages 494-502

  Friedmann, Alison M ^a,b   Tarbell, Nancy J ^a,b   Schaefer, Pamela W ^a,b   Hoch, Benjamin L ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SIZE; CASE REPORT; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; EXOPHTHALMOS; FEBRILE NEUTROPENIA; HUMAN; INFANT; LIVER VEIN OBSTRUCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT RHABDOMYOSARCOMA; ORBIT TUMOR; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; TREATMENT INDICATION; BIOPSY; CLINICAL OBSERVATION; CLINICAL STUDY; COMPUTER ASSISTED RADIOTHERAPY; DIAGNOSIS; EMBRYONAL RHABDOMYOSARCOMA; MEGAVOLTAGE RADIOTHERAPY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; COMBINED MODALITY THERAPY; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; ORBITAL NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, HIGH-ENERGY; RHABDOMYOSARCOMA, EMBRYONAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1642540096     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcpc030036     Document Type: Article

References (28)

1. Hill DA, O'Sullivan MJ, Zhu X, et al. Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study. Am J Surg Pathol 2002;26:965-77.
2. Weiss S, Goldblum JR, Rhabdomyosarcoma. In: Strauss M, ed. Soft tissue tumors. St. Louis: CV, Mosby, 2001:785-835.
3. Kelly KM, Womer RB, Sorensen PH, Xiong QB, Barr FG. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 1997;15:1831-6.
4. Sorensen PHB, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. J Clin Oncol 2002;20:2672-9.
5. Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993;71:1904-22.
6. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-I: a final report. Cancer 1988;61:209-20.
7. Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13:610-30.
8. Oberlin O, Rey A, Anderson J, et al. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment - results of an international workshop. J Clin Oncol 2001;19:197-204.
9. Wilbur JR. Combination chemotherapy for embryonal rhabdomyosarcoma. Cancer Chemother Rep 1974;58:281-4.
10. Crist WM, Anderson JR, Meza JL, et al. Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001;19:3091-102.
11. Notis CM, Abramson DH, Sagerman RH, Ellsworth RM. Orbital rhabdomyosarcoma: treatment or overtreatment. Ophthalmic Genet 1995;16:159-62.
12. Rousseau P, Flamant F, Quintana E, Voute PA, Gentet JC. Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study. J Clin Oncol 1994;12:516-21.
13. Stobbe GD, Dargeon HW. Embryonal rhabdomyosarcoma of the head and neck in children and adolescents. Cancer 1950;3:826-36.
14. Sagerman RH, Cassady JR, Tretter P. Radiation therapy for rhabdomyosarcoma of the orbit. Trans Am Acad Ophthalmol Otolaryngol 1968;72:849-54.
15. Cassady JR, Sagerman RH, Tretter P, Ellsworth RM. Radiation therapy for rhabdomyosarcoma. Radiology 1968;91:116-20.
16. Wharam MD, Hanfelt JJ, Tefft MC, et al. Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II. Int J Radiat Oncol Biol Phys 1997;38:797-804.
17. Wharam M, Beltangady M, Hays D, et al. Localized orbital rhabdomyosarcoma: an interim report of the Intergroup Rhabdomyosarcoma Study Committee. Ophthalmology 1987;94:251-4.
18. Heyn R, Ragab A, Raney RB Jr, et al. Late effects of therapy in orbital rhabdomyosarcoma in children: a report from the Intergroup Rhabdomyosarcoma Study. Cancer 1986;57:1738-43.
19. Halperin EC. Pediatric radiation oncology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1999.
20. Heyn R, Haeberlen V, Newton WA, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol 1993;11:262-70.
21. Tucker MA, D'Angio GJ, Boice JD Jr, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987;317:588-93.
22. Raju MR. Proton radiobiology, radiosurgery and radiotherapy. Int J Radiat Oncol Biol Phys 1995;67:237-59.
23. Spiro IJ, Smith AR, Lomax A, Loeffler JS. Proton beam radiation therapy. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds, Cancer: principles and practice of oncology. 6th ed. Vol. 2. Philadelphia: Lippincott Williams & Wilkins, 2001:3229-35.
24. Suit H, Goitein M, Muazenrider J, et al. Evaluation of the clinical applicability of proton beams in definitive fractionated radiation therapy. Int J Radiat Oncol Biol Phys 1982;8:2199-205.
25. Hug EB, Sweeney RA, Nurre PM, Holloway KC, Slater JD, Munzenrider JE. Proton radiotherapy in management of pediatric base of skull tumors. Int J Radiat Oncol Biol Phys 2002;52:1017-24.
26. Loeffler JS, Smith AR, Suit HD. The potential role of proton beams in radiation oncology. Semin Oncol 1997;24:686-95.
27. Noel G, Habrand JL, Helfre S, et al. Proton beam therapy in the management of central nervous system tumors in childhood: the preliminary experience of the Centre de Protontherapie d'Orsay. Med Pediatr Oncol 2003;40:309-15.
28. Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiaton-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002;54:824-9.